AC006486.9 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000470087} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/57688/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/57688/ihc_cell_selected_60x60.jpg) | ![](/images/57688/133031_B_5_5_rna_selected_60x60.jpg) | Tissue enhanced |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes Predicted intracellular proteins
| ![](/images/10022/24728_A_1_8_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10022/24783_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
AP000349.2 | PP13850 {ECO:0000313|EMBL:AAQ15253.1} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
C1orf64 | Chromosome 1 open reading frame 64 | Predicted intracellular proteins
| ![](/images/26676/ihc_selected_60x60.jpg) | ![](/images/26676/609_E8_1_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26676/55166_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C1QTNF6 | C1q and tumor necrosis factor related protein 6 | Predicted intracellular proteins
| | ![](/images/2042/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/2042/8633_B_7_1_rna_selected_60x60.jpg) | Tissue enhanced |
C8orf31 | Chromosome 8 open reading frame 31 | Predicted intracellular proteins
| ![](/images/46799/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/46799/ihc_cell_selected_60x60.jpg) | ![](/images/46799/107386_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
CACNA1G | Calcium channel, voltage-dependent, T type, alpha 1G subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/4714/ihc_selected_60x60.jpg) | ![](/images/4714/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/4714/13325_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
CEMIP | Cell migration inducing protein, hyaluronan binding | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/7090/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/7090/98041_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CTC-429P9.4 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000472547} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/22261/158690_A_2_8_rna_selected_60x60.jpg) | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/50509/ihc_cell_selected_60x60.jpg) | ![](/images/50509/126328_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
FAP | Fibroblast activation protein, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| ![](/images/59739/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/59739/134100_B_5_1_rna_selected_60x60.jpg) | Tissue enhanced |
FBXL22 | F-box and leucine-rich repeat protein 22 | Predicted intracellular proteins
| ![](/images/54627/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/54627/ihc_cell_selected_60x60.jpg) | ![](/images/54627/130301_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
FREM1 | FRAS1 related extracellular matrix 1 | Disease related genes Predicted intracellular proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GABRP | Gamma-aminobutyric acid (GABA) A receptor, pi | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| ![](/images/14883/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14883/33458_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GAS1 | Growth arrest-specific 1 | Cancer-related genes Predicted secreted proteins
| ![](/images/66902/155616_A_2_3_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/66902/155615_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
GDF7 | Growth differentiation factor 7 | Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GJC1 | Gap junction protein, gamma 1, 45kDa | Predicted intracellular proteins Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
GLI1 | GLI family zinc finger 1 | Predicted intracellular proteins Transcription factors
| ![](/images/9460/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9460/27300_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
GUCY1A2 | Guanylate cyclase 1, soluble, alpha 2 | Enzymes FDA approved drug targets Predicted intracellular proteins
| ![](/images/9534/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9534/32695_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
HOXA10 | Homeobox A10 | Predicted intracellular proteins Transcription factors
| ![](/images/19384/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/19384/152661_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
HOXA10-HOXA9 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000421799} | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HOXD10 | Homeobox D10 | Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HOXD11 | Homeobox D11 | Cancer-related genes Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images/55155/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HOXD4 | Homeobox D4 | Predicted intracellular proteins Transcription factors
| ![](/images/70349/155005_A_7_5_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/70349/155001_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
HOXD9 | Homeobox D9 | Predicted intracellular proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
HTR1E | 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| ![](/images/4931/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4931/13240_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| ![](/images/12867/155361_A_9_4_selected_60x60.jpg) | ![](/images/63658/1361_B8_2_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/12867/155357_B_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
IL17C | Interleukin 17C | Predicted secreted proteins
| ![](/images/65051/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/65051/150075_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
IL17RD | Interleukin 17 receptor D | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| ![](/images/39577/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43550/108926_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
ITGA11 | Integrin, alpha 11 | Predicted membrane proteins
| ![](/images/51813/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51813/118180_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
KCNAB3 | Potassium voltage-gated channel, shaker-related subfamily, beta member 3 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KCNG1 | Potassium voltage-gated channel, subfamily G, member 1 | Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| ![](/images/40024/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/40024/93063_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
KLHL13 | Kelch-like family member 13 | Predicted intracellular proteins
| ![](/images/46039/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46039/103620_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
LEFTY2 | Left-right determination factor 2 | Disease related genes Predicted secreted proteins
| ![](/images/47883/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47883/117287_B_7_2_rna_selected_60x60.jpg) | Tissue enhanced |
LIMS3 | LIM and senescent cell antigen-like domains 3 | Predicted intracellular proteins
| ![](/images/58455/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58455/135872_B_3_6_rna_selected_60x60.jpg) | Tissue enhanced |
LIMS3L | LIM and senescent cell antigen-like domains 3-like | Predicted intracellular proteins
| ![](/images/58455/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58455/135872_B_3_6_rna_selected_60x60.jpg) | Tissue enhanced |
LINGO2 | Leucine rich repeat and Ig domain containing 2 | Predicted membrane proteins
| ![](/images/16633/ihc_selected_60x60.jpg) | ![](/images/16633/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/25361/60808_A_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
LONRF2 | LON peptidase N-terminal domain and ring finger 2 | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MEIS3 | Meis homeobox 3 | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| ![](/images/46699/ihc_selected_60x60.jpg) | ![](/images/46699/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/46699/116435_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
MEX3A | Mex-3 RNA binding family member A | Predicted intracellular proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
MOXD1 | Monooxygenase, DBH-like 1 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/35740/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35740/72082_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
MSX1 | Msh homeobox 1 | Disease related genes Predicted intracellular proteins Transcription factors
| ![](/images/26198/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/26198/54101_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
MUC16 | Mucin 16, cell surface associated | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/55172/ihc_cell_selected_60x60.jpg) | ![](/images/55172/120598_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
NPAS4 | Neuronal PAS domain protein 4 | Predicted intracellular proteins Transcription factors
| ![](/images/39255/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39255/84733_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
OSR2 | Odd-skipped related transciption factor 2 | Predicted intracellular proteins Transcription factors
| ![](/images/52425/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/52425/124179_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
PAMR1 | Peptidase domain containing associated with muscle regeneration 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| ![](/images/39823/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39823/97556_B_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
PLK5 | Polo-like kinase 5 | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/35024/157959_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
PTGFR | Prostaglandin F receptor (FP) | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |